Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The neural interface market is full of startups vying to put technology into the human brain, but which will actually make brains a business?
AMC, the world’s largest movie theater chain, said Thursday that it filed to offer up to $350 million of stock.
To combat a crippling pilot shortage, PSA Airlines is dangling bonus packages worth $250,000 to lure pilots.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
It’s still a tumultuous time to be a major media conglomerate, Disney and Warner Bros. Discovery’s earnings reports’ show.
Nestlé is investing $100 million into Wonder Group, Marc Lore’s food-truck-turned-regular food delivery startup.
This is the third school year of the NCAA’s NIL era, granting student-athletes the right to benefit from their Name, Image, and Likeness.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
From cosmetics to apparel to tech, Western brands are seeing revenues dip in China as consumers navigate a struggling post-pandemic economy.
Moderna posted a quarterly loss of $3.63 billion, half of which was accounted for by unused Covid-19 shots past their expiration date.
Shares of Starbucks jumped more than 9% Thursday after the company posted better-than-expected Q4 earnings.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.